Prepubertal and pubertal growth, timing and duration of puberty and attained adult height in patients with congenital hypothyroidism (CH) detected by the neonatal screening programme for CH — a longitudinal study
The DOI matches its Crossref record.
Abstract
OBJECTIVE: We have evaluated parameters of growth, the pubertal process and attained adult height in patients with congenital hypothyroidism (CH) of various aetiologies, diagnosed by the neonatal screening programme, and followed up longitudinally. To the best of our knowledge, no such data are available in the published literature. Our aim was to define the most important factors affecting these parameters. PATIENTS AND MEASUREMENTS: Thirty patients with CH (20 females and 10 males) diagnosed by neonatal screening (dysgenetic (n = 15), ectopic thyroid (n = 11), and enzymatic defect (n = 4)), treated with levo‐thyroxine (L − T 4) since the age of ≤ 4 months, and followed up at intervals of 1–6 months for a mean period of 11.4 (range 5–19.6) years were evaluated. Detailed anthropometric measurements were performed by the same trained nurse, and pubertal stages were evaluated according to Tanner's criteria for breast or genitalia and pubic hair. Serum T 4 and TSH levels were measured at each clinic visit using commercial kits. Bone age (BA) was determined at 6–12 month intervals using the Greulich & Pyle method. Seventeen patients attained adult height at the time of the report. RESULTS: Mean L − T 4 dose of 7.9 (range 5.2–14.0) to 2.4 (range 1.3–3.4) μg/kg/day at various ages corrected the serum free T 4 (f‐T 4) levels to normal (> 10 pmol/l) in 95% of determinations, and the TSH level was reduced to < 10 mIU/l in 54% of the determinations during the follow‐up period. Length at initiation of therapy (mean −0.15, (range −2.5–2.1) SDS), height at onset of puberty (mean −0.4, (range −1.8–1.8) SDS) and adult height (mean 0.2 (range −1.4–2.0) SDS, n = 17) were within the normal range (0.00 ± 2 SDS). Onset and duration of puberty were normal in both sexes, and total pubertal growth contributed 19.1% (M) and 16.4% (F) to adult height. Peak height velocity (mean 10.6 (range 7.3–15.1) (M) and mean 8.0 (range 6.2–15.5) (F) cm/year) was within the normal range and occurred at the expected BA (14y;M and 12y; F). The attained average adult height was in close proximity to the average target height in both males and females. A significant positive correlation was found between the average L − T 4 daily dose administered during the first 6 months of treatment and the attained adult height. CONCLUSIONS: Early detection by neonatal screening and treatment of congenital hypothyroidism enables normal prepubertal and pubertal growth and achievement of normal adult height, following normal puberty. Adult height in congenital hypothyroidism is significantly correlated with parental height and the mean L − T 4 daily dose administered over the first 6 months of treatment. A dose of at least 8.5μg/kg/day is recommended during this period. Periodical adjustments of L − T 4 daily dose should be guided by clinical observation and serum free T 4 levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Salerno, M., Militerni, R., Bravaccio, C., Micillo, M., Capalbo, D., Di Maio, S., & Tenore, A. (2002) · Thyroid · doi:10.1089/105072502753451968 · Cited by 165
“Growth in patients with CH detected by neonatal screening is generally normal (19–22) however, recent evidence suggests that the amount of LT 4 in the first 6 months of life strongly influences the attainment of normal adult height (23).”
Salerno, M., Micillo, M., Di Maio, S., Capalbo, D., Ferri, P., Lettiero, T., & Tenore, A. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450377 · Cited by 123
Factors predicting final height in early treated congenital hypothyroid patients
Delvecchio, M., Salerno, M., Acquafredda, A., Zecchino, C., Fico, F., Manca, F., Faienza, M. F., & Cavallo, L. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02651.x · Cited by 27
Children with congenital hypothyroidism are at risk of adult obesity due to early adiposity rebound
Wong, S. C., Ng, S. M., & Didi, M. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02116.x · Cited by 27
“…linear growth in children with congenital hypothyroidism (CH), with few recent studies reporting normal final adult height in patients from different parts of the world (Grant, 1994; Dickerman & De Vries, 1997; Salerno et al ., 2001; Bain et al ., 2002; Morin et al ., 2002; Adachi et al ., 2003).”
BackgroundDelvecchio, M., Vigone, M. C., Wasniewska, M., Weber, G., Lapolla, R., Popolo, P. P., Tronconi, G. M., Di Mase, R., De Luca, F., Cavallo, L., et al. (2015) · Italian Journal of Pediatrics · doi:10.1186/s13052-015-0190-y · Cited by 22
“Linear growth, onset and progression of puberty, pubertal growth and final height (FH) are reported as rather normal in patients diagnosed thorough the screening, and the target height (TH) is the most important factor determining linear growth [3–8].”
BackgroundResult
Metadata
- Authors
- Dickerman, Z., & De Vries, L.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1997-12
- Volume
- 47
- Issue
- 6
- Pages
- 649-654
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2121655931
- Cited by
- 58
- References
- 0
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prepubertal and pubertal growth, timing and duration of puberty and attained adult height in patients with congenital hypothyroidism (CH) detected by the neonatal screening programme for CH — a longitudinal study. https://app.cochat.ai/papers/10.1046/j.1365-2265.1997.3181148.x
- The paper
- Dickerman, Z., & De Vries, L. (1997). Prepubertal and pubertal growth, timing and duration of puberty and attained adult height in patients with congenital hypothyroidism (CH) detected by the neonatal screening programme for CH — a longitudinal study. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.1997.3181148.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.